1099Sinopharm Group
−2.1% today · −13.3% over a year
No score: too little data.
Stability: among the best of its peers. Dividend yield 4.95%.
Sinopharm Group (1099) belongs to the Health care sector and is listed on HKEX; country: China. Over the past 12 months the price changed by −13.3%, with an annualised volatility of 21% and a largest fall of 30%.
Smart Score
How it is scored →Not scored: not enough data for a fair comparison.
Factor scores
Percentiles within the peer group (100 = the best of its peers); dividend safety in points.
Main drivers
- Volatility (1 y)supports the score · better than 95% of peers
- Betasupports the score · better than 89% of peers
- Max drawdown (3 y)supports the score · better than 86% of peers
Red flags and notes
No red flagsNone of our published warning rules is triggered right now.
Price chart
Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.
Key metrics
Dividends
- Dividend yield
- 4.95%
- 5-year dividend growth (per year)
- −1.2%
- Years of dividend growth
- 1
Returns and risk
- 1 day
- −2.1%
- 1 month
- +7.1%
- 1 year
- −13.3%
- Volatility, 1 yr
- 21.4%
- Max drawdown, 1 yr
- −29.7%
- Beta
- 0.67
Returns are price changes from end-of-day prices, without dividends.
Similar companies
Same sector, closest in price swings over the past year.
| TAKTakeda Pharmaceutical Co Ltd | —/10 | 0.0% | 42.9% |
|---|---|---|---|
| 4502Takeda Pharmaceutical Co., Ltd. | —/10 | 3.2% | 56.0% |
| LONNLonza Group AG | —/10 | 0.8% | 11.6% |
| SNYSanofi | 7/10 | 5.0% | −12.7% |
| SANSanofi SA | 8/10 | 5.5% | −8.6% |
| NOVNNovartis AG | 10/10 | 2.9% | 34.7% |
| RORoche Holding AG (bearer shares) | —/10 | 2.7% | 52.9% |
| GSKGSK plc | 10/10 | 3.7% | 11.4% |
News and filings
No recent news or filings in our sources.
Score changes in the last 12 months
Every published rating and change, logged when it was published (EU Market Abuse Regulation).
No published ratings in the last 12 months.
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.